StemCells Inc Share Price Nasdaq
Stocks
US85857R3030
Biotechnology & Medical Research
| Market Cap | 119M 104M 96.08M 89.95M 169M 11.21B 172M 1.15B 447M 5.54B 446M 437M 19.22B | P/E 2026 * |
-5.9x | P/E 2027 * | -5.53x |
|---|---|---|---|---|---|
| Enterprise Value | 119M 104M 96.08M 89.95M 169M 11.21B 172M 1.15B 447M 5.54B 446M 437M 19.22B | EV / Sales 2026 * |
34.5x | EV / Sales 2027 * | 11.2x |
| Free-Float |
100% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: StemCells Inc
| 1 day | -19.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 54 | 01/08/1988 |
Rachel Vaknin
DFI | Director of Finance/CFO | 47 | 31/03/2022 |
Michal Ahuvia
COO | Chief Operating Officer | - | 20/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Burell
BRD | Director/Board Member | 61 | 27/11/2016 |
| Director/Board Member | 68 | 11/12/2017 | |
Tal Wenderow
BRD | Director/Board Member | 52 | 31/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -19.35% | +575.21% | - | - | 119M | |
| -0.48% | +7.20% | -5.08% | +2.45% | 46.2B | |
| +2.19% | +11.71% | +385.81% | +632.13% | 38.71B | |
| +2.53% | +13.93% | +20.85% | -10.61% | 31.9B | |
| +1.65% | +3.61% | +9.98% | +55.42% | 31.12B | |
| -4.16% | -2.58% | +8.74% | +15.22% | 23.77B | |
| -0.32% | +12.96% | - | - | 16.2B | |
| +1.37% | +14.53% | +71.80% | +134.14% | 15.05B | |
| +1.00% | +10.30% | +13.31% | +22.84% | 13.74B | |
| +3.63% | +9.53% | +104.07% | +107.62% | 13.42B | |
| Average | -1.19% | +9.14% | +76.18% | +119.90% | 25.57B | |
| Weighted average by Cap. | +0.74% | +8.71% | +86.69% | +140.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.45M 3.02M 2.79M 2.61M 4.89M 325M 5M 33.51M 12.97M 161M 12.95M 12.67M 558M | 10.6M 9.29M 8.57M 8.02M 15.04M 1B 15.35M 103M 39.84M 494M 39.8M 38.93M 1.71B |
| Net income | -20.45M -17.93M -16.53M -15.47M -29.02M -1.93B -29.62M -199M -76.87M -953M -76.79M -75.11M -3.31B | -21.45M -18.81M -17.34M -16.23M -30.43M -2.02B -31.07M -208M -80.63M -1B -80.54M -78.79M -3.47B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
